HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter S Jensen Selected Research

Combined Modality Therapy

2/2022Variable Patterns of Remission From ADHD in the Multimodal Treatment Study of ADHD.
1/2021A Qualitative Analysis of Contextual Factors Relevant to Suspected Late-Onset ADHD.
1/2020Trajectories of Growth Associated With Long-Term Stimulant Medication in the Multimodal Treatment Study of Attention-Deficit/Hyperactivity Disorder.
11/2018Maternal ADHD Symptoms, Personality, and Parenting Stress: Differences Between Mothers of Children With ADHD and Mothers of Comparison Children.
1/2018Introduction: Just Say No? New Insights About Change Versus Constancy in Substance Use Behavioral Decisions in Youth With and Without ADHD.
1/2018Follow-Up of Young Adults With ADHD in the MTA: Design and Methods for Qualitative Interviews.
1/2018How Substance Users With ADHD Perceive the Relationship Between Substance Use and Emotional Functioning.
1/2018The Qualitative Interview Study of Persistent and Nonpersistent Substance Use in the MTA: Sample Characteristics, Frequent Use, and Reasons for Use.
6/2017Young adult outcomes in the follow-up of the multimodal treatment study of attention-deficit/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression.
11/2016Functional Adult Outcomes 16 Years After Childhood Diagnosis of Attention-Deficit/Hyperactivity Disorder: MTA Results.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter S Jensen Research Topics

Disease

47Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
02/2022 - 05/2002
6Substance-Related Disorders (Drug Abuse)
01/2018 - 08/2007
4Mental Disorders (Mental Disorder)
11/2020 - 02/2003
2Mood Disorders (Mood Disorder)
12/2017 - 08/2012
2Mania (Manias)
09/2015 - 03/2007
2Bipolar Disorder (Manic Depressive Psychosis)
09/2015 - 03/2007
2Rheumatoid Arthritis
07/2014 - 03/2011
2Tic Disorders (Tic Disorder)
03/2007 - 06/2006
1Major Depressive Disorder (Major Depressive Disorders)
01/2022
1Epilepsy (Aura)
01/2021
1Hyperkinesis
02/2011
1Psychotic Disorders (Schizoaffective Disorder)
03/2007
1Conduct Disorder (Conduct Disorders)
02/2006
1Attention Deficit and Disruptive Behavior Disorders (Disruptive Behavior Disorder)
06/2003

Drug/Important Bio-Agent (IBA)

28Pemetrexed (MTA)FDA Link
02/2022 - 05/2002
7Methylphenidate (Ritalin)FDA LinkGeneric
02/2015 - 01/2003
4Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric
02/2015 - 06/2006
3Amphetamine (Amfetamine)FDA LinkGeneric
02/2015 - 11/2006
2Neurotransmitter Agents (Neurotransmitter)IBA
01/2021 - 08/2012
2Guanfacine (Tenex)FDA LinkGeneric
02/2015 - 02/2011
2Lisdexamfetamine DimesylateFDA Link
02/2015 - 02/2011
2Clonidine (ST 155)FDA LinkGeneric
02/2015 - 02/2011
2Risperidone (Risperdal Consta)FDA LinkGeneric
03/2007 - 02/2006
2Antipsychotic Agents (Antipsychotics)IBA
03/2007 - 02/2003
1Antidepressive Agents (Antidepressants)IBA
01/2022
1gamma-Aminobutyric Acid (GABA)IBA
01/2021
15-HT2A Serotonin Receptor (5 HT2A Receptor)IBA
11/2020
1Biological ProductsIBA
11/2018
1Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
12/2017
1trans-sodium crocetinate (crocetin)IBA
12/2015
1Brain-Derived Neurotrophic Factor (BDNF)IBA
09/2015
1DNA (Deoxyribonucleic Acid)IBA
09/2015
1Serotonin (5 Hydroxytryptamine)IBA
08/2012
1Pharmaceutical PreparationsIBA
03/2011
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2011
1Valproic Acid (Depakote)FDA LinkGeneric
12/2009
15'-N-methylcarboxamideadenosineIBA
05/2007
1Quetiapine Fumarate (Seroquel)FDA Link
03/2007
14,4'-dibenzamido-2,2'-stilbenedisulfonic acidIBA
03/2007
1ziprasidone (Geodon)FDA Link
03/2007
1Olanzapine (Zyprexa)FDA Link
03/2007
1Clozapine (Clozaril)FDA LinkGeneric
03/2007
1Pemoline (Cylert)FDA Link
06/2006
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
05/2006
1Explosive Agents (Explosives)IBA
06/2003

Therapy/Procedure

37Combined Modality Therapy
02/2022 - 05/2002
5Drug Therapy (Chemotherapy)
02/2011 - 06/2003
2Therapeutics
07/2014 - 11/2006
2Aftercare (After-Treatment)
02/2011 - 05/2009